ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, cilt.79, sa.7, ss.604-607, 2000 (SCI-Expanded)
Background. There is still no cost-effective endometrial screening method for asymptomatic postmenopausal breast cancer patients using tamoxifen. We investigated the effectivity of transvaginal ultrasonography and endometrial sampling as a screening method for asymptomatic patients. Additionally the effect of tamoxifen on hypothalamus-pituitary axis and serum lipid profiles were investigated.